All In MedTech

FDA Clearance Tracker · P230021-S003

Duo Venous Stent System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Feb 12, 2026 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Feb 12, 2026

Approved

Time to decision

139 days

Received Sep 26, 2025. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P230021-S003
Device name
Duo Venous Stent System
Applicant location
Plymouth, MN
Received
Sep 26, 2025
Decided
Feb 12, 2026
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P230021

Device type

Device class
Class III

Every decision under product code QAN

FDA's approval statement

As written in FDA's record.

Approval of the updated Instruction for Use for both the Duo Venous Stent System (Pin/Pull delivery system) and Duo Venous Stent System (Triaxial Handle delivery system) with final results of the VIVID study.

Source documents

Other decisions for Philips Image Guided Therapy Corporation

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

6 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.